Dow Down 0.08% Nasdaq Down 0.35%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.88 Feb 9, 3:57PM EST
Prev Close:1.88
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:12.80
Beta:1.60454
Earnings Date:Feb 22 - Feb 26 (Est.)
Day's Range:N/A - N/A
52wk Range:1.69 - 8.64
Volume:0
Avg Vol (3m):215,852
Market Cap:13.11M
P/E (ttm):N/A
EPS (ttm):-2.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OPXA

Comparison

Symbol% ChgMkt Cap
OPXA 0.00%13.11M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.86
Quarterly EPS Est (Dec-15) :-0.50
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback